DDX5001P-50 Anti-Remicade (Infliximab) antibody

See related secondary antibodies

Search for all "Anti-Remicade (Infliximab)"

50 µg / €190.00
Please visit the country specific website of Acris Antibodies or contact your local Distributor to buy this product.

Quick Overview

Mouse anti Human Anti-Remicade (Infliximab) 108G4.03

Product Description for Anti-Remicade (Infliximab)

Mouse anti Human Anti-Remicade (Infliximab) 108G4.03.
Presentation: Purified
Product is tested for ELISA capture and detection, Functional assay.

Properties for Anti-Remicade (Infliximab)

Product Category Primary Antibodies
Quantity 50 µg
Presentation Purified
Reactivity Hu
Applications E(caption)/E(detection), FN
Clonality Monoclonal
Clone 108G4.03
Host Mouse
Isotype IgG1
Shipping to Germany, USA/Canada
PDF datasheet View Datasheet
Manufacturer Dendritics SAS

Datasheet Extract

Remicade® (Janssen Biologics B.V.) (Infliximab)
Application DDX5001P-50 DDX5001P-100 Purified: Bridging ELISA positive control for anti-Remicade detection, Inhibition of Remicade binding to TNF-α, Capture antibody for Remicade detection. 
DDX5001B-50 DDX5001B-100 Biotin: Detection antibody for Remicade detection.

Usage recommendation:

*This monoclonal antibody may be used between 5-25μg/ml.
*Optimal dilution should be determined by each laboratory for each application.
*Coupled antibody: to maintain RT before use.
Background Remicade® (Infliximab) is a chimeric monoclonal antibody targeting TNF-α, used for the treatment of autoimmune diseases such as rheumatoid arthritis, ankylosis spondylitis, Crohn’s disease, psoriatic arthritis or ulcerative colitis. We have generated a panel of anti-Remicade® (anti-Infliximab) monoclonal murine antibodies. These antibodies can be used to develop and calibrate Remicade (Infliximab) and anti-Remicade (anti-Infliximab) detection assays.
Concentration 0.5 mg/ml
Storage -20°C. KEEP CONTENTS STERILE: no preservative.
Purified antibodies: avoid repeated freeze/thaw cycles.
Coupled antibodies: glycerol protects from freezing.
QMA Hyper D ion exchange chromatography
Buffer System:
Purified: 100 μg in 200 μl / 50 μg in 100 μl Tris-NaCl pH 8.
Coupled: 100 μg in 200 μl / 50 μg in 100 μl PBS 50% glycerol.
Remicade® (Infliximab). 
Cross-reactivity: negative for rituximab (mabthera) and roactemra (tocilizumab).

Accessory Products

  • LinkedIn